Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 446 | 0 | 0 | 0 | 0 |
| Cost of Goods | 468 | 0 | N/A | N/A | N/A |
| Gross Profit | -22 | N/A | N/A | N/A | N/A |
| Operating Expenses | 104,070 | 52,742 | 77,642 | 35,687 | 12,042 |
| Operating Income | -103,624 | -52,742 | -77,642 | -35,687 | -12,042 |
| Interest Expense | 0 | 0 | 0 | 0 | 1,036 |
| Other Income | -38,681 | -27,287 | -48,068 | -69,615 | 60 |
| Pre-tax Income | -142,305 | -80,029 | -125,710 | -105,302 | -13,019 |
| Income Tax | 4 | -4 | -2 | 3 | N/A |
| Net Income Continuous | -142,309 | -80,025 | -125,708 | -105,305 | -13,019 |
| Net Income | $-142,309 | $-80,033 | $-125,712 | $-105,305 | $-13,019 |
| EPS Basic Total Ops | -3,973.01 | -3,729.39 | -10,757.12 | -104,535.20 | -10,607.20 |
| EPS Basic Continuous Ops | -3,971.22 | -3,727.96 | -10,756.80 | -100,687.90 | -10,606.91 |
| EPS Diluted Total Ops | -3,973.01 | -3,729.39 | -10,757.12 | -104,535.20 | -10,607.20 |
| EPS Diluted Continuous Ops | -3,971.22 | -3,727.96 | -10,756.80 | -100,687.90 | -10,606.91 |
| EPS Diluted Before Non-Recurring Items | -2,923.54 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-103,322 | $-52,479 | $-77,380 | $-35,443 | $-11,973 |